A combination of human leukocyte antigen DQB1*02 and the tumor necrosis factor alpha promoter G308A polymorphism predisposes to an insulin-deficient phenotype in patients with type 2 diabetes - Li, H; Groop, L; Nilsson, A (J Clin Endocrinol Metab, 2003)
et al.